(Vienna, 28 July 2021) Jolanta Siller-Matula, MedUni Vienna cardiologist, has been awarded the Werner Klein Research Award for Translational Cardiovascular Research. The research award was presented during the annual conference of the Austrian Society of Cardiology (ÖKG), which was held as a virtual event from 27 to 29 May 2021.
The Werner Klein Research Award for Translational Cardiovascular Research, sponsored by Bayer Austria, is awarded by the ÖKG for continued excellence in the field of cardiovascular research. The award is particularly aimed at work that builds a bridge between basic research and clinical research.
The research team led by Jolanta Siller-Matula is investigating the optimal combinations and duration of application of antithrombotic drugs in patients undergoing percutaneous coronary and structural interventions. A recent meta-analysis conducted by her research team, which was also recognised by the award, examined whether a short-term dual antiplatelet therapy (DAPT) followed by a ticagrelor monotherapy is associated with an improved clinical outcome than standard DAPT. In patients with acute coronary syndrome, short-term DAPT followed by ticagrelor monotherapy resulted in an unchanged ischaemic risk but a significantly lower risk of bleeding than standard DAPT. Short-term DAPT followed by ticagrelor monotherapy therefore had a better safety and efficacy profile.
About Jolanta Siller-Matula
Jolanta Siller-Matula is an Associate Professor and interventional cardiologist specialising in coronary and structural cardiac interventions at the Department of Medicine II, Division of Cardiology of MedUni Vienna. She is a leader of an international research group I-COMET (International Cardiovascular and Cardiometabolic Research Team), which is currently exploring personalised treatments and diagnostic biomarkers for cardiovascular and cardiometabolic diseases. Siller-Matula research uses interdisciplinary approaches grounded in the fields of interventional cardiology, haemostasology and clinical pharmacology, with a special focus on personalised antithrombotic therapy. She has published more than 150 peer-reviewed papers, which have been cited more than 4,500 times according to Scopus (Hirsch index 35) and she is assistant editor for Circulation Cardiovascular Intervention. Jolanta Siller-Matula also works as an adjunct professor at the Medical University of Warsaw.